Symbols / VIH
VIH Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
News
RSS: Latest VIH news- The 2025 HIV Market Report: The state of the HIV market in low- and middle-income countries - Clinton Health Access Initiative ue, 25 Nov 2025 08
- BofA Securities raises Gilead Sciences stock price target to $154 on HIV franchise strength - Investing.com Fri, 09 Jan 2026 08
- US FDA approves Gilead's twice-yearly injection for HIV prevention - Reuters Wed, 18 Jun 2025 07
- Knowing HIV Viral Load Doesn’t Improve Number of Patients Seeking Needed Care - poz.com Fri, 26 Dec 2025 08
- Elimination of Division of HIV Prevention Could Have Consequences for HIV Response - The American Journal of Managed Care® (AJMC®) ue, 25 Mar 2025 07
- Gilead stock rises after positive HIV treatment trial results - Investing.com hu, 13 Nov 2025 08
- Gilead's HIV Drugs Power Earnings Beat, Company Eyes Multiple Launches By 2026 - Benzinga Fri, 31 Oct 2025 07
- Health & HIV - Unicef Fri, 07 Mar 2025 21
- A Step Closer to an Effective HIV Vaccine - Columbia University Irving Medical Center ue, 17 Dec 2024 08
- Frustration mounts as Uganda faces HIV treatment shortages - Devex hu, 03 Apr 2025 07
- Global Status of HIV/AIDS Pandemic Takes Center Stage in Opening Session - The American Journal of Managed Care® (AJMC®) Mon, 10 Mar 2025 07
- Can AI Spark New Progress Against HIV? - Duke Global Health Institute Fri, 02 Aug 2024 07
- GSK delivers continued strong performance - GSK Wed, 30 Jul 2025 07
- Canada’s VIH Aviation Group Becomes Sikorsky’s First S-92A+™ Kit Launch Customer - Lockheed Martin Mon, 27 Apr 2020 07
- Impact of US funding cuts on HIV programmes in Angola - UNAIDS ue, 15 Apr 2025 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for VIH
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|